Mechanisms of action of atypical antipsychotic drugs: a critical analysis

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Psychopharmacology

• Publication date

  1996-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF02245602PMID 8935797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Chronic Treatment of Haloperidol and Clozapine on Levels of G-Protein Subunits in Rat Striatum

  2017cited by this paper
• Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats.

  2009cited by this paper
• The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat

  2006cited by this paper
• Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats

  2005cited by this paper
• Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study

  2005cited by this paper
• Regional blockade by neuroleptic drugs ofin vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies

  2005cited by this paper
• Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

  2005cited by this paper
• Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia

  2005cited by this paper
• Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients

  2005cited by this paper
• Seroquel: electrophysiological profile of a potential atypical antipsychotic

  2005cited by this paper
• Pharmacologic properties of (−)-3PPP (preclamol) in man

  2005cited by this paper
• Atypical neuroleptics suppress dopaminergic behavioral supersensitivity

  2005cited by this paper
• Haloperidol and clozapine treatment and their effect onM-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine

  2005cited by this paper
• Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans — a PET study with [11C]SCH 23390 and [11C]raclopride

  2005cited by this paper
• Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol

  2005cited by this paper
• Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

  2005cited by this paper
• Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat

  2005cited by this paper
• High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET

  2005cited by this paper
• Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

  2005cited by this paper
• Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice

  2005cited by this paper
• Clozapine improves dizocilpine-induced delayed alternation impairment in rats

  2005cited by this paper
• d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

  2005cited by this paper
• Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates

  2005cited by this paper
• Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat

  2005cited by this paper
• Glycine site antagonists abolish dopamine D 2 but not D 1 receptor mediated catalepsy in rats

  2005cited by this paper
• Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

  2005cited by this paper
• Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics

  2005cited by this paper
• Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs

  2005cited by this paper
• Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients

  2005cited by this paper
• Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

  2005cited by this paper
• Effect of clozapine on the metabolism of serotonin in rat brain

  2004cited by this paper
• Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: Studies with chronic clozapine and haloperidol

  2004cited by this paper
• Glutamate in schizophrenics and healthy controls

  2004cited by this paper
• Symptomatic relief from treatment‐induced psychosis in Parkinson's disease: An open‐label pilot study with remoxipride

  2004cited by this paper
• Clozapine: neuroleptic-induced EPS and tardive dyskinesia

  2004cited by this paper
• Metoclopramide: Antipsychotic efficacy of a drug lacking potency in receptor models

  2004cited by this paper
• Basic biology of clozapine: electrophysiological and neuroendocrinological studies

  2004cited by this paper
• Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug‐induced psychosis

  2004cited by this paper
• Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics

  2004cited by this paper
• Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat

  2004cited by this paper
• Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats

  2004cited by this paper
• Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat

  2004cited by this paper
• Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

  2004cited by this paper
• The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions

  2004cited by this paper
• Effect of serotonin antagonism in schizophrenia: A pilot study with setoperone

  2004cited by this paper
• D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

  2004cited by this paper
• Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

  2004cited by this paper
• Interaction of clozapine with the histamine H3 receptor in rat brain

  1995cited by this paper
• Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs

  1995cited by this paper
• Effects of prazosin on the dopaminergic neurotransmission in rat brain.

  1995cited by this paper
• Polymorphic tandem repeats in dopamine D4 receptor are spread over primate species.

  1995cited by this paper
• Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment.

  1995cited by this paper
• Correlation between tryptophan hydroxylase activity in the brain and predisposition to pinch-induced catalepsy in mice.

  1995cited by this paper
• Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.

  1995cited by this paper
• Effects of the σ receptor ligand SR 31742A on neurotensin biosynthesis in rat basal ganglia

  1995cited by this paper
• Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

  1995cited by this paper
• 5-HT2A serotonin receptors in the brain of rats and mice hereditarily predisposed to catalepsy.

  1995cited by this paper
• Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

  1995cited by this paper
• Further studies on the effects of chronic clozapine on regional extracellular dopamine levels in the brain of conscious rats.

  1995cited by this paper
• The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine.

  1995cited by this paper
• [The level of catecholamines and dihydroxyphenylacetic acid in the brain of rats with a hereditary predisposition to catalepsy].

  1995cited by this paper
• Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia

  1995cited by this paper
• Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist.

  1995cited by this paper
• Cerebral ventricular enlargement and neuroleptic response in chronic schizophrenia: Preliminary findings with risperidone

  1995cited by this paper
• 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).

  1995cited by this paper
• Clozapine: Selective Labeling of Sites Resembling 5HT6 Serotonin Receptors May Reflect Psychoactive Profile

  1995cited by this paper
• D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.

  1995cited by this paper
• Seroquel (ICI 204 636), a putative “atypical” antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters

  1995cited by this paper
• Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.

  1995cited by this paper
• The level of catecholamines and dihydroxyphenylacetic acid in the brain of rats with a hereditary predisposition to catalepsy

  1995cited by this paper
• Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.

  1994cited by this paper
• Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred.

  1994cited by this paper
• Remoxipride and raclopride differ from metoclopramide by their effects on striatal dopamine release and biosynthesis in rats.

  1994cited by this paper
• The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding.

  1994cited by this paper
• The Effect of Clozapine on Plasma Norepinephrine: Relationship to Clinical Efficacy

  1994cited by this paper
• INFLUENCE OF α1‐ADRENOCEPTOR ANTAGONISM OF KETANSERIN ON THE NATURE OF ITS 5‐HT2 RECEPTOR ANTAGONISM

  1994cited by this paper
• Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic‐induced dyskinesias

  1994cited by this paper
• Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression.

  1994cited by this paper
• Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations

  1994cited by this paper
• Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs.

  1994cited by this paper
• Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion

  1994cited by this paper
• Altered striatal function in a mutant mouse lacking D1A dopamine receptors.

  1994cited by this paper
• Motor and mental aspects of acute extrapyramidal syndromes

  1994cited by this paper
• Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis.

  1994cited by this paper
• Survey on the pharmacodynamics of the new antipsychotic risperidone

  1994cited by this paper
• Blockade of Striatal 5‐Hydroxytryptmine2 Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐Methylenedioxymethamphetamine

  1994cited by this paper
• Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.

  1994cited by this paper
• Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja.

  1994cited by this paper
• Opposing Roles for Dopamine D2 and D3 Receptors on Neurotensin mRNA Expression in Nucleus Accumbens

  1994cited by this paper
• Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists

  1994cited by this paper
• Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo.

  1994cited by this paper
• Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.

  1994cited by this paper
• Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule

  1994cited by this paper
• Amelioration of negative symptoms in schizophrenia by glycine.

  1994cited by this paper
• Depression as a lethal disease: prevention strategies.

  1994cited by this paper
• Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats

  1994cited by this paper
• Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors

  1994cited by this paper
• Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients

  1994cited by this paper
• Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs.

  1994cited by this paper
• Comparison of short-term administration of sertindole, clozapine and haloperidol on the inactivation of midbrain dopamine neurons in the rat.

  1994cited by this paper

• Comparative receptor pharmacology of antipsychotic drugs based on normalized binding affinity data and breadth of interaction.

  2025cites this paper
• Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome: A Case Report

  2025cites this paper
• From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials

  2025cites this paper
• Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation

  2025cites this paper
• Psychotropic Taxonomies: Constructing a Therapeutic Framework for Psychiatry

  2024cites this paper
• How to classify antipsychotics: time to ditch dichotomies?

  2023cites this paper
• Biophysical analyses of rodent behavior in neuroscience research: A tribute to Dr. Stephen C. Fowler.

  2022cites this paper
• Review On: Recent Trends in Antipsychotic Formulations

  2022cites this paper
• Consequences of Antipsychotic Medications on Mental Health.

  2022cites this paper
• Physicochemical Insights on Terahertz Wave Diminished Side Effects of Drugs from Slow Dissociation.

  2022cites this paper
• Atypical antipsychotics and CD36 pathway.

  2021cites this paper
• Automated design and optimization of multitarget schizophrenia drug candidates by deep learning

  2020cites this paper
• The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia

  2020cites this paper
• Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms

  2019cites this paper
• An overview on the synthetic and medicinal perspectives of indenopyrazoles.

  2019cites this paper
• Striatal dopamine, functional connectivity, and salience processing in health and disease

  2019cites this paper
• Clozapine administered repeatedly following pretreatment with ketamine enhances dopamine D2 receptors in the dopamine mesolimbic pathway in mice brain.

  2019cites this paper
• Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment.

  2019cites this paper
• Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis

  2018cites this paper
• Mining the Potential of Label-Free Biosensors for In Vitro Antipsychotic Drug Screening

  2018cites this paper
• Metaphor Comprehension in Schizophrenic Patients

  2018cites this paper
• The development of antipsychotic drugs

  2018cites this paper
• Clozapine Intoxication Mimicking Acute Stroke

  2018cites this paper
• A systems neuroscience perspective on treatment resistant schizophrenia : the role of cognitive control, reinforcement learning, and myelination

  2018influential citation
• The Ambit of Phytotherapy in Psychotic Care

  2018cites this paper
• The Role of Antipsychotic Medications in Metabolic Syndrome Amongst aPredisposed Population: Review of The Saudi Case

  2017cites this paper
• Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis

  2017cites this paper
• Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study

  2016cites this paper
• Synthesis and biological evaluation of new 6-hydroxypyridazinone benzisoxazoles: Potential multi-receptor-targeting atypical antipsychotics.

  2016cites this paper
• Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.

  2016cites this paper
• Involvement of the histamine H4 receptor in clozapine-induced hematopoietic toxicity: Vulnerability under granulocytic differentiation of HL-60 cells.

  2016cites this paper
• Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, 
Present and Future

  2016cites this paper
• Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

  2016cites this paper
• Motivational Deficits in Schizophrenia

  2016cites this paper
• The Dopamine Hypothesis of Schizophrenia

  2016cites this paper
• Synthesis and evaluation of amide, sulfonamide and urea – benzisoxazole derivatives as potential atypical antipsychotics

  2015cites this paper
• Effects of central activation of serotonin 5-HT2A/2C or dopamine D2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test

  2015cites this paper
• Effects of Clozapine on Perceptual Abnormalities and Sensory Gating: A Preliminary Cross-Sectional Study in Schizophrenia

  2015cites this paper
• Aripiprazole-associated tic in a schizophrenia patient

  2015cites this paper
• Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents?

  2014cites this paper
• Quetiapine-Related Tic in a Pediatric Bipolar Patient

  2014cites this paper
• Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.

  2014cites this paper
• Synthesis and evaluation of new coumarin derivatives as potential atypical antipsychotics.

  2014cites this paper
• Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.

  2014cites this paper
• Design and synthesis of novel 2H-chromen-2-one derivatives bearing 1,2,3-triazole moiety as lead antimicrobials.

  2014cites this paper
• Frontal lobe synaptic plasticity in development and disease: modulation by the dopamine D1 receptor.

  2014cites this paper
• A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens

  2014cites this paper
• Interregional Connectivity in People with Schizophrenia: A Study Using Visual Evoked Potentials

  2013cites this paper
• Effects of antipsychotic drugs on the expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal cultures

  2013cites this paper
• Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report

  2013cites this paper
• Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics.

  2013cites this paper
• Paliperidone protects prefrontal cortical neurons from damages caused by MK-801 via Akt1/GSK3β signaling pathway.

  2013cites this paper
• Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression

  2013cites this paper
• Paliperidone Extended-Release: Safety and Tolerability from a Metabolic Profile Perspective

  2013influential citation
• The Effectiveness of Treatments for Cocaine Dependence in Schizophrenic Patients: A Systematic Review

  2013cites this paper
• Is Brain-derived Neurotrophic Factor a Possible Mechanism Underlying Risperidone Sensitization in Adolescent Rats?

  2013cites this paper
• Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs.

  2013cites this paper
• Effect of D‐cycloserine in conjunction with fear extinction training on extracellular signal‐regulated kinase activation in the medial prefrontal cortex and amygdala in rat

  2013cites this paper
• Poster #13 RECEPTOR BINDING PROFILES OF ANTIPSYCHOTIC MEDICATIONS AND GLUCOSE DYSREGULATION: AN ACUTE ANIMAL MODEL

  2012cites this paper
• Treatment Response in First-episode Schizophrenia

  2012cites this paper
• Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism

  2012cites this paper
• Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells

  2012cites this paper
• MATHEMATICAL MODEL FOR SUPPRESSION OF GLUCOCORTICOID SECRETION BY USING A LOG-LOGISTIC STEP-STRESS MODEL

  2012cites this paper
• How Human Electrophysiology Informs Psychopharmacology: from Bottom-up Driven Processing to Top-Down Control

  2011cites this paper
• Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity

  2011cites this paper
• Risk of osteoporosis and fracture incidence in patients on antipsychotic medication

  2011influential citation
• Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide25-35, N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death

  2011cites this paper
• The interaction of antipsychotic drugs with lipids and subsequent lipid reorganization investigated using biophysical methods.

  2011cites this paper
• Factors affecting interindividual differences in clozapine response: a review and case report

  2011cites this paper
• Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures.

  2011cites this paper
• Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning

  2010cites this paper
• Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

  2010cites this paper
• A decade of progress in the discovery and development of 'atypical' antipsychotics.

  2010cites this paper
• 11 – Clinical psychopharmacology

  2010cites this paper
• Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway.

  2010cites this paper
• SVEUILIŠTE U ZAGREBU MEDICINSKI FAKULTET

  2010cites this paper
• The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.

  2010cites this paper
• The 'atypicality' of antipsychotics: a concept re-examined and re-defined

  2009cites this paper
• Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment.

  2009cites this paper
• Comparing acute toxicity of first- and second-generation antipsychotic drugs: a 10-year, retrospective cohort study.

  2009cites this paper
• Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome.

  2009cites this paper
• Interrupción del efecto de inhibición latente por la administración de Mk-801

  2009cites this paper
• Antipsychotic Drug Treatment for Patients with Schizophrenia: Theoretical Background, Clinical Considerations and Patient Preferences

  2009cites this paper
• Biological mechanisms behind clozapine- induced agranulocytosis

  2009cites this paper
• Neuroanatomical, Neurochemical, and Neurodevelopmental Basis of Obsessive-Compulsive Symptoms in Schizophrenia

  2009cites this paper
• Typical and atypical antipsychotics alter acetylcholinesterase activity and ACHE expression in zebrafish (Danio rerio) brain.

  2009cites this paper
• Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats.

  2009cites this paper
• Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.

  2009cites this paper
• Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance.

  2009cites this paper
• What CATIE did: some thoughts on implications deep and wide.

  2008cites this paper
• Issues Associated with the Use of Atypical Antipsychotic Medications

  2008cites this paper
• Detection of the Moderately Beneficial Cognitive Effects of Low-Dose Treatment with Haloperidol or Clozapine in an Animal Model of the Attentional Impairments of Schizophrenia

  2008cites this paper
• Eosinophilic Meningoencephalitis: Psychiatric Presentation and Treatment

  2008cites this paper
• Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression

  2008cites this paper
• Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells.

  2008influential citation
• Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.

  2008cites this paper
• How CATIE brought us back to Kansas: a critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia

  2008cites this paper
• Diagnosing and managing psychotic and mood disorders.

  2008cites this paper
• Olanzapin

  2008cites this paper
• Effects of Typical and Atypical Antipsychotic Drugs on Rat Brain Muscarinic Receptors

  2007cites this paper